amgen
Tag details
Welcome to the 'amgen' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'amgen'.
Look up
"amgen"
at The Free Dictionary
Latest blogosphere posts tagged “amgen”
-
Alder Rides Momentum of $1B Deal, Aims to Give Amgen and Abbott a Run for Their Money
Xconomy —
Authority: 714
Biotech , deals , people Luke Timmerman wrote: Alder Biopharmaceuticals keeps such a low profile that even after five years in business, few people in Seattle biotech know who they are. That changed yesterday as the private Bothell, WA-based company burst onto the local, and national, biotech scene by ...1 day ago -
Alder Scores Deal With Bristol-Myers Potentially Worth $1 Billion
Xconomy —
Authority: 714
Biotech , deals , Rheumatoid Arthritis Luke Timmerman wrote: Alder Biopharmaceuticals has just struck one of the biggest biotech partnerships of the year, both in the Seattle area and nationally. The Bothell, WA-based developer of faster and cheaper technology for making antibody drugs has formed a ...1 day ago -
Looking Back: 2009 Tour of California a Perfect Barometer for Later Season Success
Euro Peloton - Pro Cycling News —
Authority: 123
The 2009 Amgen Tour of California proved to be a good barometer for who would shine in 2009. Held in February at the beginning of the season, the nine day race was long enough and tough enough to show who would have the chops later in the season. Now scheduled for May, next years race will be a great indicator for who ...2 days ago -
Aranesp Associated With Increased Risk For Stroke In Patients With Diabetes And Chronic Kidney Disease
Drug Injury Watch —
Authority: 110
TREAT Study Revealed, Also, That This Amgen Anemia Drug Was No Better Than Placebo In Reducing Deaths Or Cardiovascular Problems (Posted by Tom Lamb at DrugInjuryWatch.com ) The anemia drug Aranesp (darbepoetin alfa) might cause an increased risk for stroke in patients with diabetes and ...5 days ago -
Impactiviti Daily 110209
Impactiviti blog —
Authority: 542
TODAY’S NEWS Takeda buys into Amylin ’s weight-loss drug portfolio – Takeda will pay $75 million upfront for medicines including Amylin’s pramlintide/metreleptin and davalintide, in the second phase of testing needed for U.S. regulatory approval, Osaka- based Takeda and San Diego-based Amylin said in ...1 week ago -
Amylin Strikes $1 Billion Deal with Takeda to Co-Develop Weight Loss Drugs
Xconomy —
Authority: 714
Biotech , deals , obesity Luke Timmerman wrote: San Diego-based Amylin Pharmaceuticals, the dark horse in the race to develop a new breed of weight-loss drugs, has struck a partnership with Japan-based Takeda Pharmaceuticals that could be worth more than $1 billion over time if the drug reaches ...1 week ago -
15 States Including California Are Suing Amgen – Alleging Kickbacks and Overfill Billings to Boost Sales of Aranesp
The Medical Quack —
Authority: 514
The drug, Aranesp is used with chemotherapy and chronic renal failure to increase red blood cells and was approved by the FDA in 2001. We are hearing more about drug marketing today and now it’s spilling over to the “biotech” drug companies for investigation. The suit states that providers were bribed and ...1 week ago -
Amgen Is Accused of Illegal Kickbacks
NYT > Theater —
Authority: 913
Amgen has been accused by 14 states of engaging in illegal kickbacks to promote sales of its anemia drug Aranesp.1 week ago -
Amgen Sued By 15 States Over Aranesp Kickbacks
Pharmalot —
Authority: 595
The lawsuit charges Amgen - along with a specialty group purchasing organization known as International Nephrology Network and the ASD Healthcare wholesaler - with offering kickbacks to medical providers to increase sales of its Aranesp anemia drug, Aranesp. The multi-state suit, by the way, joins a whistleblower ...1 week ago -
14 States and DC Sue Amgen, Amerisource Over Alleged Kickbacks
HULIQ - Citizen News Review —
Authority: 704
The attorneys general of 14 states and the District of Columbia have filed a lawsuit against drugmaker Amgen Inc. and a major pharmaceutical distributor charging the companies colluded to defraud the Medicaid program and offer illegal kickbacks to physicians in order to boost sales of Amgens anemia drug Aranesp.1 week ago -
Amgen Sued By New York, 14 Other States
socalTECH.com - Southern California High Tech News —
Authority: 561
Thousand Oaks-based biotech giant Amgen is the subject of a lawsuit being filed by New York Attorney General Andrew M. Cuomo, along with 14 other states, claiming that the biotech firm created a kickback scheme to boost drug sales. According to Cuomo, the lawsuit, filed today in federal court, claims that Amgen, ...1 week ago -
All of your cycling news – October 29, 2009
Bike World News —
Authority: 141
In todays cycling news, confusion reigns around Contador, Bellis to return to Britain, Team Sky adds strength, Cadel Evans determined to win Tour de France and more... For the full story, go to http://www.bikeworldnews.com1 week ago -
UK Trust Sues Amgen & Wyeth Over Enbrel Patent
Pharmalot —
Authority: 595
The Mathilda and Terence Kennedy Institute of Rheumatology Trust filed its lawsuit in federal court in Delaware, seeking royalties and damages from Wyeth and Amgen for infringing a patent for treating arthritis. The drug makers jointly market Enbrel, a best-selling med, for treating rheumatoid arthritis. In its ...2 weeks ago -
Santaris Nabs Isis, Amgen Vets
Xconomy —
Authority: 714
Biotech , people , MicroRNA Luke Timmerman wrote: Santaris Pharma , the Danish company that has pushed the first microRNA therapy into clinical trials, has recruited a pair of big name executives from Isis Pharmaceuticals and Amgen Ventures to help lead its new U.S. subsidiary in San Diego. Mark Wedel, ...2 weeks ago -
Team Type 1 reveals 2010 Pro Men’s Roster
Bike World News —
Authority: 141
Team Type 1 will field a versatile roster sprinkled with international flavor and experience when it begins its third season as a men’s professional team in 2010. For the full story, go to http://www.bikeworldnews.com2 weeks ago -
Armstrong to Miss Giro
Come Cycling With Me —
Authority: 134
LOS ANGELES (USA): Lance Armstrong is set to miss next year’s Giro d’Italia after announcing he will race in the Tour of California. The California race starts on May 16 while the Giro, the world’s second-biggest stage race, begins on May 8. The seven-time Tour de France winner finished 12th in this year’s ...2 weeks ago -
All of your cycling news – October 23, 2009
Bike World News —
Authority: 141
In todays bicycle racing news, a Dutch face for the Giro, Footon-Servetto and Caisse dEpargne transfers, AToC looks to be a Tour de France warmup, Ricco returns and more... For the full story, go to http://www.bikeworldnews.com2 weeks ago -
(AMGN) Amgen Beats – Raises Guidance
Stock Blog Hub —
Authority: 506
Amgen (AMGN) reported third quarter earnings per share of $1.47, well above the Zacks Consensus Estimate of $1.26 and 21% above the year-ago earnings of $1.21. Cost cuts and a lower tax rate helped boost the top-line despite a 2% decline in total revenues, which came in at $3,812 million. Total product sales ...2 weeks ago -
2010 Giro dItalia vs. Amgen Tour of California: The Opening Salvo
Euro Peloton - Pro Cycling News —
Authority: 123
In what is sure to be an annual occurance, the Amgen Tour of California today announced its official route and host cities, along with several big name American riders that will ride in the May stage race. Lance Armstrong, Levi Leipheimer, George Hincapie and David Zabriskie are confirmed participants, and the list ...2 weeks ago -
Snap Judgment – 2010 Amgen Tour of California Route
| Triple Crankset A Cycling Blog with Some Teeth —
Authority: 122
The Amgen Tour of California returns next year in May, rather than in its traditional February calendar spot with an eight-day stage race that will take participants from Nevada City to the Thousand Oaks area, home base of Amgen. Many of the top American riders, including defending champion, Levi Leipheimer , have ...2 weeks ago